Healthcare Industry News:  XLIF 

Diagnostics Personnel

 News Release - December 5, 2006

Medical Professional With 47 years Experience Appointed to Physician Relations Role for MediSys Corporation

PALM BEACH GARDENS, Fla., Dec. 5 (HSMN NewsFeed) -- MediSys Corporation (Pink Sheets: MDYS ) announced today that it has appointed Alan H. Weigand, MD, as the Company's new Director of Clinical Education. Dr. Weigand, who currently sits on the Clinical Advisory Board, is scheduled to assume this additional role and take on its varied responsibilities beginning January 2, 2007.

Dr. Weigand is a medical professional with more than 47 years of combined experience in education, research and consulting in healthcare and clinical medicine. For over a decade he participated in the management of a program studying erectile dysfunction at the University of Medicine & Dentistry of New Jersey at Newark. As part of this special program, Dr. Weigand conducted electro-diagnostic research and studies on approximately 900 patients exhibiting symptoms of ED.

Dr. Weigand's new role with MediSys, Director of Clinical Education, was created to offer the Company's physician-clients access to an expert on erectile dysfunction studies, as well as to make available a physician liaison for the Company's MaXLIFe Center for Men(TM) program. In this role, he will offer assistance to physician-clients regarding the addition of a mens' health component to their existing practice.

According to Joshua Konigsberg, CEO of MediSys Corporation, "Bringing aboard someone of Dr. Weigand's stature and experience is invaluable, as it will help us better educate the medical community on the MediSys vision and the many benefits of the MaXLIFe Center for Men program. His research and studies on erectile dysfunction could not be more relevant to our core program. His presence will serve to enhance our marketing activities, and should also play a role in the rapid expansion of our centers nationwide."

Dr. Weigand commented, "I consider this position an opportunity to not only assist MediSys Corporation, but even more importantly, to help teach physicians nationwide how to experience increased success from their medical practice. In today's family practice environment, it is critical for physicians to seek alternative and additional revenue sources, such as that offered by MediSys and the MaXLIFe Center for Men. The net result for these physicians will be the ability to stabilize practice profits, as well as increase overall earnings."

Dr. Alan H. Weigand received his medical degree in 1959 from the Jefferson Medical College of Philadelphia (now Thomas Jefferson University Hospital). His long career includes the completion of residency training in physical medicine and rehabilitation, a three-year program, at the VA Medical Center in East Orange, NJ, which is affiliated with Albert Einstein School of Medicine. In 1975, he was hired into the department of physical medicine & rehabilitation at the VA Medical Center in East Orange, NJ, where he was later appointed Director of that facility's electro-diagnostic laboratory. When this program merged into the University of Medicine & Dentistry of New Jersey program, he was appointed Clinical Professor of physical medicine & rehabilitation. Dr. Weigand also served as Director of Rehabilitation Medicine, at the Daughters of Miriam Center, in Clifton, NJ, for 12 years from 1984 to 1996.

About MediSys

MediSys Corporation provides medical diagnostic solutions to physicians in the internal medicine, family medicine and general practice markets. The Company's innovative clinical programs are easily integrated into the physicians practice, are cost-effective and enhance patient care. These programs or "systems" enable doctors to provide superior medical diagnostics & treatment while significantly improving their revenues and profits. Please visit our corporate website for more information: .

Disclaimer Regarding Forward-Looking Statements:

This announcement may contain certain forward-looking statements that are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated. Forward-looking statements speak only as of the date the statement was made. The Company assumes no obligation to update forward-looking information to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information. If the Company does update any forward-looking statement, no inference should be drawn that the Company will make additional updates with respect to that statement or any other forward-looking statements.

Source: MediSys Corp

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.